Roundup Cancer Lawsuit News

The International Agency For Research on Cancer Insists They Do Not Cherry Pick Studies

The IARC is angry at Monsanto for questioning their scientific ethics and defends their position as a fiercely independent world cancer watchdog organization

Tuesday, December 18, 2018 - Monsanto has appealed a multi-million dollar jury verdict awarded to a California school maintenance workers for developing cancer from using Roundup herbicide. Monsanto has accused the jury of dealing in "junk science" while ignoring hundreds of studies by the likes of the US Environmental Protection Agency (EPA) and others that have found no conclusive evidence that glyphosate causes cancer.

One of the arguments used extensively by Monsanto in a court of law as well as the court of public opinion is that the International Agency for Cancer Research (IARC)'s designation of glyphosate as being probably carcinogenic is tainted by the agency's lack of scientific expertise. At issue here is a article that states that the IARC falsely accused the chemical benzene as a source of cancer in humans. National attorneys represent people that developed cancer after working with Roundup and continue to file Roundup cancer lawsuits.

Now the IARC is fighting back and defending the efficacy of their scientific procedures. In particular, the IARC has been accused of cherry-picking the studies to include or to be left out of their research in order to skew their findings against glyphosate's safety. According to the official IARC website, "the IARC strongly rejects the premise of the article published on 28 February 2018 by Reuters (WHO cancer agency "left out key findings" in benzene review). No key findings were left out of the IARC evaluation of benzene as a cause of cancer, and IARC provided extensive responses to Dr. Kopstein's questions. The article, which severely distorts the assessment of the IARC Monographs evaluation, is the latest in a series of misleading reports by Reuters. In the best interests of global public health and transparency, IARC is posting its full response to the journalist on its website, as it has consistently done." While there is no relationship between benzene and glyphosate, the Reuters article drew a parallel in order to attempt to discredit the IARC's cancer-review process in general.

The IARC glyphosate cancer designation has lit a firestorm of litigation against Monsanto by citizens and activists all over the world. When the IARC designated glyphosate as "probably cancer-causing in humans" the chemical was automatically included on the state of California's Proposition 65 list of chemicals sold in the state and can cause cancer. Such an automatic inclusion on the California list was challenged in court by Monanto on constitutional grounds, however, the state's opinion prevailed. Monsanto was successful in blocking the state from requiring the company to label bottles of Roundup to include a cancer warning. The first court case alleging glyphosate and Roundup as being cancer-causing was decided against Monsanto further reinforcing glyphosate's cancer-causing reputation. As an additional concern, glyphosate is sprayed in such enormous quantities that the health of the entire world is at stake should the chemical, in fact, cause cancer or other human diseases. Scientists are currently studying glyphosate's relationship to causing other 21 century human diseases such as the current epidemics of autism, and obesity among others.

More Recent Roundup Cancer Lawsuit News:

Lawyers for Roundup Cancer Lawsuits

Attorneys handling Roundup cancer lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Roundup cancer lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Roundup cancer lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.